Received Jun 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | — |
mild headache; fever; muscle and joint problems; muscle and joint problems; Flu-like symptoms; Initial information received on 29-May-2026 regarding an unsolicited valid non-serious case received from a non-healthcare professional (consumer). This case involves a 77-year-old female patient who experienced mild headache, fever, muscle and joint problems, and flu-like symptoms after receiving NVX-COV2705 (OMICRON JN. 1) Adjuvanted Vaccine (Nuvaxovid). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. Concomitant medication(s) included cefalexin (Keflex 2000mg). In Oct-2025, the patient received a dose unknown, 1x (one time) dose of NVX-COV2705 (Omicron Jn.1) Adjuvanted Vaccine dispersion for injection (batch/lot number: asked but unknown; expiry date: unknown) (strength: unknown) via unknown route in an unknown administration site for immunization [Immunisation]. The patient reported that she had received her first dose of NUVAXOVID last Oct-2025, and at the "very least of it," she experienced a mild headache (Headache, onset: Unknown, latency: unknown), and that was it. The patient further reported that in the past, when she received the Pfizer vaccines, she experienced a 102°F fever (Pyrexia, onset: unknown, latency: unknown), "muscle and joint problems" (Muscle disorder, onset: unknown, latency: unknown; Arthropathy, onset: unknown, latency: unknown), for like five to six days, and felt "flu-like" symptoms (Influenza like illness, onset: unknown, latency: unknown). Action taken: Not applicable. Corrective treatment: Not reported. Event outcome: Unknown
Comments: NONE
Keflex